(b) Company acknowledges MJE’s and Provider’s proprietary rights in and to the Provider IP Rights, including, without limitation, Provider’s name, nick name, voice, image and likeness. In that regard, MJE shall have the right to prohibit any use, display, performance, reproduction, broadcast, amplification, whitelisting, transmission, exhibition, dissemination and distribution by Company utilizing Provider’s name, nick name, image or likeness, or any other Provider IP Rights, in each case which, in MJE’s reasonable discretion, harms or impairs, or could reasonably be expected to harm or impair, the reputation or goodwill of MJE or Provider. Any use, display, performance, reproduction, broadcast, amplification, whitelisting, transmission, exhibition, dissemination or distribution of any Provider IP Rights, including Provider’s name, nick name, image or likeness, in each case in connection with the promotion of the Company, its affiliates and/or the Products, including advertising of any public appearance by Provider, shall be consistent with the terms of, and shall be governed by, this Agreement and subject to the prior written approval of MJE in each instance, which approval shall not be unreasonably withheld, conditioned or delayed. In the event that Company utilizes the name, nick name, image and/or likeness of Provider or any other Provider IP Rights in violation of this paragraph or any other terms of this Agreement, then in addition to any other rights and remedies provided by this Agreement and/or at law, MJE shall have the right to injunctive relief to cease such violation.
(c) In addition to the standards required above, Company acknowledges the great value of the goodwill associated with Provider and Provider’s name, nick name, image, likeness, initials, mark, appearance, signature (including reproduced signature), autograph, endorsement, voice and biographical material (including history, video and motion picture film portrayals, and still photography) (hereinafter collectively referred to as the “Provider IP Rights”), and the worldwide recognition thereof. Company agrees that it will not use the Provider IP Rights in any manner which, directly or indirectly, would reasonably be expected to degrade, tarnish or deprecate or disparage Provider’s public image and/or the Provider IP Rights. Specifically, the Company shall not permit the publication, distribution, transmission, broadcast, exhibition and/or online posting of any Works incorporating the Provider IP Rights that represent, depict or promote (i) the glorification of violence, including but not limited to any representations of gang- or terrorist-related imagery, firearms or explosive devices, (ii) sexual activities, including but not limited to any representations of body parts or sex toys, (iii) religious beliefs, including but not limited to any religious iconography or any image commonly associated with any religious organization or cult, (iv) any political content or (v) tobacco, alcohol or drug use (collectively, the “Prohibited Uses”). In the event that Company utilizes the Provider IP Rights in violation of this paragraph, then in addition to any other rights and remedies provided by this Agreement and/or at law, MJE shall have the right to injunctive relief to cease such violation. Subject to Section 5(d), any and all goodwill arising from Company’s use of the Provider IP Rights pursuant to this Agreement is and will be owned by MJE, and/or will inure to MJE’s sole benefit. Company acknowledges and agrees that MJE and/or Provider have sole and exclusive ownership of the Provider IP Rights and of the goodwill associated therewith, including any and all goodwill that arises during or from the use thereof, and that nothing contained in this Agreement shall give Company any right, title or interest in the Provider IP Rights except for the limited rights expressly licensed to Company in, and subject to, this Agreement. Company shall not file any intellectual property applications or seek registration thereof in the Provider IP Rights or any derivations, variations or modifications thereof, without Provider’s prior written approval in each instance.
- 7 -